Antibodies are back for thymic attack in cGVHD. - Wikidata - wikimedia - TriplyDB

Antibodies are back for thymic attack in cGVHD.

Antibodies are back for thymic attack in cGVHD.

http://www.wikidata.org/entity/Q36876960

about

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.B-cell targeting in chronic Graft-versus-Host disease.

P2860

Q38405199-04920A06-59C3-4068-9FB9-89CB099B6B8A Q50044417-C381E48B-6459-4162-BBE4-5567AED76E66

P2860

Antibodies are back for thymic attack in cGVHD.

http://www.wikidata.org/entity/Q36876960

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antibodies are back for thymic attack in cGVHD.

@en

type

label

Antibodies are back for thymic attack in cGVHD.

@en

prefLabel

Antibodies are back for thymic attack in cGVHD.

@en

P1433

Q36876960-777B0E86-78D4-4AD5-BD72-D77A5CABDFA6

P1476

Q36876960-11B7E292-FA2B-42E2-9087-01A785E1764D

P2860

Q36876960-35140C53-3193-48ED-93BC-2F4B6B35432D

Q36876960-3F8FAC1D-81DC-4B26-A701-1FA50ED0E684

Q36876960-522FD1B1-B666-4695-86B0-542351926240

Q36876960-75CC6B78-CCF7-4C68-B850-F2434E30F087

Q36876960-76438DF5-CD2E-4739-9184-71DCC88F267A

Q36876960-89E87F80-9BB0-472D-BEFE-F62953F23185

Q36876960-9377C533-2D4F-4039-B37F-8B9EFAD5A8CD

Q36876960-95BB02A5-C453-464F-9712-2AA757413E76

Q36876960-D5763C5E-62FA-4EA0-A5EC-238FF748901B

Q36876960-DA7146C7-0D25-4B92-B42C-921A87FB575D

P304

Q36876960-3B21AC98-7B12-4D94-9823-93E28862C6FB

P31

Q36876960-C97015E6-212C-45FE-9987-E7F7FAF502C5

P356

Q36876960-8F64A99B-AF8F-4E0D-9F59-4274F50E42FF

P407

Q36876960-1BBD2F21-52AE-4A0F-A142-3991BF5D8546

P433

Q36876960-A5344296-D3A9-4672-A214-C111F90B7383

P478

Q36876960-6F0118F4-3A56-4621-9589-9FF5591EDFA1

P50

Q36876960-35A87DFF-F34C-4DBB-9A1A-98C68C646AF3

P577

Q36876960-B9D02CE9-A1E0-4AE9-994B-A606B69A39FD

P5875

Q36876960-C578E0B6-E200-4FFC-AB0D-C65CCE5E85EB

P698

Q36876960-F7E1C6B7-D05D-4E6A-913B-0AE94ECF92E5

P932

Q36876960-210C07DA-B5CD-4176-90A7-639F77033A36

P356

BLOOD-2016-03-701706

P1433

P1476

Antibodies are back for thymic attack in cGVHD.

@en

P2860

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease

Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

Advances in graft-versus-host disease biology and therapy.

Aberrant B-cell homeostasis in chronic GVHD

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

Rituximab for steroid-refractory chronic graft-versus-host disease.

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.

Emergent autoimmunity in graft-versus-host disease.

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.

P304

2170-2171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-03-701706

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie Sarantopoulos

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301937065

http://www.w3.org/2001/XMLSchema#string

P698

27151737

http://www.w3.org/2001/XMLSchema#string

P932

4859194

http://www.w3.org/2001/XMLSchema#string